
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Drug discount program : improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony  before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives</dc:title>
  <dc:subject>United States. Health Resources and Services Administration</dc:subject>
  <dc:subject>Drug Costs</dc:subject>
  <dc:subject>Economics, Pharmaceutical</dc:subject>
  <dc:subject>Pharmacies -- economics</dc:subject>
  <dc:subject>Contract Services</dc:subject>
  <dc:subject>Government Regulation</dc:subject>
  <dc:publisher>Washington, DC : United States Government Accountability Office, July 11, 2018</dc:publisher>
  <dc:contributor>United States. Government Accountability Office, issuing body.</dc:contributor>
  <dc:contributor>United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, issuing body.</dc:contributor>
  <dc:type>Technical Report</dc:type>
  <dc:format>Text</dc:format>
  <dc:format>1 online resource (1 PDF file (9 pages))</dc:format>
  <dc:identifier>nlm:nlmuid-101766006-pdf</dc:identifier>
  <dc:identifier>101766006</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101766006</dc:identifier>
  <dc:language>English</dc:language>
  <dc:coverage>United States</dc:coverage>
  <dc:rights>The National Library of Medicine believes this item to be in the public domain. https://creativecommons.org/publicdomain/mark/1.0</dc:rights>
</oai_dc:dc>